glp 1 vs sglt2 🔴SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application⤵️ #2025Review #OpenAccess 🔹https://www.e-dmj.org/journal/view.php?doi=10.4093/dmj.2025.0220 #Cardiology #FOAMed #MedEd #medstudent SGLT2i and GLP-1 RA therapy

Patient Privacy/Risk: Carrying sensitive patient data over networks must comply with HIPAA

In vitro assays with 3,4- cis -leucocyanidin (6) Standard reaction conditions for in vitro one-step and two-step biotransformations of 3,4- cis -leucocyanidin ( 6 ) were 100 mM MOPSO, pH 6.2, 20 mM sodium ascorbate, 1 mM -ketoglutaric acid, 0.4 mM ammonium iron(II) sulfate, 200 M 3,4- cis -leucocyanidin ( 6 ) and 20 M GSH

5-AMINO-1MQ COMPARED TO OTHER NAD+-ENHANCING COMPOUNDS 5-AMINO-1MQ VS

When we compared Microdose GLP-1 Rx Program members who had the new features to those who didnt (pre-post analysis), we saw the new features drove over 20% higher D30 engagement in our key app behaviors (completing a lesson, logging meals, etc.)